<code id='3C092D20A9'></code><style id='3C092D20A9'></style>
    • <acronym id='3C092D20A9'></acronym>
      <center id='3C092D20A9'><center id='3C092D20A9'><tfoot id='3C092D20A9'></tfoot></center><abbr id='3C092D20A9'><dir id='3C092D20A9'><tfoot id='3C092D20A9'></tfoot><noframes id='3C092D20A9'>

    • <optgroup id='3C092D20A9'><strike id='3C092D20A9'><sup id='3C092D20A9'></sup></strike><code id='3C092D20A9'></code></optgroup>
        1. <b id='3C092D20A9'><label id='3C092D20A9'><select id='3C092D20A9'><dt id='3C092D20A9'><span id='3C092D20A9'></span></dt></select></label></b><u id='3C092D20A9'></u>
          <i id='3C092D20A9'><strike id='3C092D20A9'><tt id='3C092D20A9'><pre id='3C092D20A9'></pre></tt></strike></i>

          entertainment

          entertainment

          author:hotspot    Page View:671
          Gavel black background lawsuits
          Adobe

          TRENTON, N.J. — Pharma industry giants including Bristol Myers Squibb, Johnson & Johnson, Novartis, and Novo Nordisk deployed a half-dozen lawyers to a courtroom here Thursday in a bid to dismantle Medicare’s new drug price negotiation program, just hours before President Biden is set to glorify it in his State of the Union.

          A federal judge in New Jersey heard an unusual quadruple oral argument in which attorneys for all four drugmakers combined forces to challenge different facets of the Inflation Reduction Act, which in 2022 empowered Medicare to negotiate the prices of a small number of drugs each year beginning in 2026.

          advertisement

          Over four hours, the debate spanned most of the substantive issues that pharmaceutical companies and their allies have raised across the country, both in constitutional challenges to the law and in challenges to how Medicare officials have interpreted the law so far. That means the court’s decision in these cases could produce a first substantive test for several of the arguments that haven’t been addressed by courts in other states, where companies like Boehringer Ingelheim, AstraZeneca, and Merck are also suing, separately, over the same law.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Sports medicine is finally prioritizing gender equality
          Sports medicine is finally prioritizing gender equality

          MollyFergusonforSTATWhencyclistAlisonTetrickjoinedthesport’sprofessionalranks,shereceivedtheperkstha

          read more
          New Alzheimer's drugs heat up race for early detection blood tests
          New Alzheimer's drugs heat up race for early detection blood tests

          MarionBerard/AFP/GettyImagesWiththeadventofdisease-modifyingAlzheimer’sdrugs,everyoneintheworldofAlz

          read more
          Tori Bowie and the unacceptable rates of Black maternal death
          Tori Bowie and the unacceptable rates of Black maternal death

          AlastairGrant/APThehorrorstoriesofBlackwomendyingorcomingclosetodeathinchildbirthneverseemtostopcomi

          read more

          Clinicians often fail to acknowledge the pain caused by long Covid

          AdobeAfterhissecondhospitalizationforacuteCovid-19,TonyMarksexpectedtogetbetter.Thenpaininvadedthe54